Glaucoma Clinical Trial
Official title:
Optical Coherence Tomography Imaging of the Posterior Segment in High Myopia.
The prevalence of myopia in East Asia and Singapore in particular is amongst the highest in the world, with estimates ranging from 30-70% of the general population. Up to 30% of these are high myopes. High myopia is associated with degenerative changes in the fundus. It may also be associated with vision-threatening complications such as macular holes. The pathogenesis of macular holes in high myopes is not completely understood but is postulated to include a combination of anterior vitreous traction and posterior staphyloma formation and axial elongation. These forces lead to degenerative changes at the macula, including foveal detachment and retinoschisis that precede the formation of lamellar or full thickness macular holes. These changes are difficult to detect either clinically or by conventional imaging such as ultrasound, making efforts to correct them in the early stages with surgery difficult. High myopia is also associated with a two- to threefold increase in risk of developing glaucoma. However, the diagnosis of glaucoma in high myopes is difficult as many of the pathological changes in the myopic eye mimic those seen in glaucoma. The myopic optic disc in particular is notoriously difficult to differentiate from the glaucomatous disc. Currently, the diagnosis is highly subjective, relying on observations of the clinical appearance of the disc or on disc photos.Optical coherence tomography (OCT) is an evolving technology that relies on time delays of reflected or backscattered light and interferometry to yield cross-sectional images of the retina and optic disc. The Stratus OCT is the latest model and has been demonstrated to be able to yield images with a resolution comparable to that of histology. It is thus potentially useful in assessing degenerative changes occurring in the myopic fundus, in evaluating the early changes preceding macular hole formation, and in providing objective measures of various disc parameters to aid in diagnosing glaucoma in high myopes. This study aims to recruit 150 healthy, young, ophthalmologically normal males from the SAF and to examine them with OCT. High myopes (≤-8D) will be selected and compared with a control group of low myopes. The performance of the OCT will be evaluated against current diagnostic methods.
Primary AimThe aim of the study is to evaluate the retinal and macular topography,
vitreomacular relationships and optic nerve head changes in highly myopic eyes of young
adults. Specific aims include:1) To determine the prevalence of vitreo-macular traction and
macular degenerations (macular thickening, detachments, schisis or lamellar holes) in
asymptomatic, highly myopic young Asian males using OCT.2) To characterize and measure optic
nerve head and peripapillary retinal nerve fibre layer changes in high myopia using OCT.3)
To compare OCT findings with current methods of investigation and diagnosis
SubjectsSubjects will be drawn from in-service personnel as well as recruits awaiting
enlistment. They will be identified based on their refraction through the SAF's computerized
medical records system.Informed consent will be sought from the subjects before
commencement. All subjects will be healthy young males and will be ophthalmologically normal
apart from myopia. The main exclusion criteria are:1) Best corrected visual acuity <6/92)
Previous intraocular surgery3) Intraocular pressure >21mmHg4) Gonioscopic findings of angle
closure5) Clinical evidence of pseudo-exfoliation, uveitis or pigment dispersion syndrome,
corneal or media opacities, retinal pathology or neurological diseases6) Family history in a
first degree relative of glaucoma or other optic neuropathy.Excluded subjects will be
replaced by the subject next-in-line in the cohort.ProcedureAll subjects identified will be
examined at SNEC/SERI by one of the investigators. The assessment for each subject will
include:1) Autorefraction performed with a non-accommodating target and recording of best
corrected visual acuity. 2) Slit lamp examination, Goldmann applanation tonometry,
gonioscopy, examination with a Goldmann three-mirror lens, and a dilated fundus examination
with a 78 diopter fundus lens. Retinal findings are recorded in standard Amsler Dubois
retinal diagrams. Grading of background myopic chorioretinal changes will be in accordance
with the scheme proposed by Avila . 3) Axial length measurements. Ultrasound A scan is
performed for each eye. Axial length is ascertained from the average of six consistent
recordings. Care is taken to locate the fovea especially in cases with posterior staphyloma,
by ensuring fixation of the A scan probe light. 4) Fundus photography with the Topcon
camera. Stereoscopic disc photographs will also be taken for comparison with OCT scans of
the optic nerve head.5) OCT using the Stratus OCTOCT measurements will be performed at one
sitting by a trained technician. The commercially prescribed Optic Disc, RNFL and Macular
Thickness scanning algorithms will be used. Each subject will fixate on an internal target
presented by the computer where possible, or an external fixation target for cases unable to
cooperate. Subjects will be encouraged to blink between the acquisition of each radial scan
to minimize discomfort and minimize the effect of an irregular tear film or corneal
desiccation on the tear film. Each scan will take approximately 2.5s, making for a total
image acquisition time of less than a minute. The optic nerve head scan consists of six
radial scans centered on the optic nerve head. The computer generated disc margin will be
used as the reference for optic nerve head measurements. The macular thickness protocol uses
six radial scans centered on the fovea. The retinal thickness is measured automatically as
the distance between the vitreoretinal interface and the junction between the inner and
outer segments of photoreceptors.
;
Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06000865 -
Glaucoma Rehabilitation With Action viDeo Games and Exercise - GRADE
|
N/A | |
Recruiting |
NCT06278597 -
Automatic Evaluation of the Anterior Chamber Angle Width by a New Non-contact Optical Device
|
N/A | |
Active, not recruiting |
NCT04271709 -
Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT)
|
N/A | |
Recruiting |
NCT03274024 -
The Asia Primary Tube Versus Trab (TVT) Study
|
N/A | |
Completed |
NCT04552964 -
Assessment of the Impact of an add-on and Its Smartphone Application on the Daily Management of Glaucoma
|
N/A | |
Recruiting |
NCT01957267 -
Functional and Structural Imaging for Glaucoma
|
||
Active, not recruiting |
NCT04624698 -
iStent Inject New Enrollment Post-Approval Study
|
N/A | |
Completed |
NCT04020705 -
The Efficacy of Citicoline in Eyedrops (OMK1) in Reducing the Progression of Glaucoma
|
N/A | |
Completed |
NCT03150160 -
Additive Effect of Twice-daily Brinzolamide 1%/Brimonidine 0.2%Combination as an Adjunctive Therapy to Travoprost in Patients With Normal Tension Glaucoma
|
Phase 4 | |
Not yet recruiting |
NCT05581498 -
Glaucoma Exercise as Medicine Study (GEMS).
|
N/A | |
Recruiting |
NCT02921568 -
Side-by-Side Comparison of P200TE and Spectral OCT/SLO on Diseased Eyes
|
N/A | |
Active, not recruiting |
NCT02901730 -
Clinical Study of LPI With Different Laser Wavelengths
|
N/A | |
Completed |
NCT02955849 -
A Trial of China Laser and Surgery Study Glaucoma in Rural China
|
Early Phase 1 | |
Recruiting |
NCT02471105 -
Investigation of IOP and Tolerability of Bimatoprost 0.01% and Tafluprost Unit Dose Preservative Free 15 Microgram/ml
|
Phase 4 | |
Recruiting |
NCT02554214 -
Pilot Clinical Trial on a New Adjustable Glaucoma Drainage Device
|
N/A | |
Active, not recruiting |
NCT02390284 -
Stop Retinal Ganglion Cell Dysfunction Study
|
Phase 3 | |
Completed |
NCT02628223 -
180 Degree vs. 360 Degree Selective Laser Trabeculoplasty as Initial Therapy for Glaucoma
|
N/A | |
Completed |
NCT02653963 -
Triamcinolone for Ahmed Glaucoma Valve
|
N/A | |
Completed |
NCT02390245 -
Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study
|
N/A | |
Completed |
NCT02246764 -
Study of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
|
Phase 3 |